Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (241-250 of 325) with videos related to

Pageof 33
Sort By:
European Journal of Dermatology : EJD|May 25, 2026
Fluid silicone gels in the prevention and treatment of hypertrophic scars: a systematic review and meta-analysis of randomised controlled trialsValeria Antoniou, Kangjie Reuel Chua, Dilip K Vankayalapati, et al.
International Journal of Molecular Sciences|April 3, 2021
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 CellsMonika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Dermatology and Therapy|June 13, 2024
Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional StudyPiotr K Krajewski, Alexandra Strobel, Michael Schultheis, et al.
Dermatology (Basel, Switzerland)|January 8, 2024
Hidradenitis Suppurativa Is Associated with Severe Sexual ImpairmentPiotr K Krajewski, Alexandra Strobel, Michael Schultheis, et al.
Pharmaceutics|February 25, 2023
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductJonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, et al.
Oncotarget|June 2, 2016
A key role of GARP in the immune suppressive tumor microenvironmentSusanne A Hahn, Annemarie Neuhoff, Jenny Landsberg, et al.
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 12, 2024
Second opinion and self-efficacy in German skin cancer patientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
The British Journal of Dermatology|May 3, 2023
A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trialMichael Schultheis, Petra Staubach, Georgios Nikolakis, et al.
Pageof 33

Showing results (241-250 of 325) with videos related to

Sort By:
Pageof 33
European Journal of Dermatology : EJD|May 25, 2026
Fluid silicone gels in the prevention and treatment of hypertrophic scars: a systematic review and meta-analysis of randomised controlled trialsValeria Antoniou, Kangjie Reuel Chua, Dilip K Vankayalapati, et al.
International Journal of Molecular Sciences|April 3, 2021
Complement-Opsonized Nano-Carriers Are Bound by Dendritic Cells (DC) via Complement Receptor (CR)3, and by B Cell Subpopulations via CR-1/2, and Affect the Activation of DC and B-1 CellsMonika Bednarczyk, Carolina Medina-Montano, Frederic Julien Fittler, et al.
Mediators of Inflammation|December 11, 2023
Comparison of Inflammatory Cytokine Levels in Hepatic and Jugular Veins of Patients with CirrhosisLeonard Kaps, Carolina Medina-Montano, Matthias Bros, et al.
Dermatology and Therapy|June 13, 2024
Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional StudyPiotr K Krajewski, Alexandra Strobel, Michael Schultheis, et al.
Dermatology (Basel, Switzerland)|January 8, 2024
Hidradenitis Suppurativa Is Associated with Severe Sexual ImpairmentPiotr K Krajewski, Alexandra Strobel, Michael Schultheis, et al.
Pharmaceutics|February 25, 2023
Quality by Design (QbD) Approach for a Nanoparticulate Imiquimod Formulation as an Investigational Medicinal ProductJonas Pielenhofer, Sophie Luise Meiser, Karsten Gogoll, et al.
Oncotarget|June 2, 2016
A key role of GARP in the immune suppressive tumor microenvironmentSusanne A Hahn, Annemarie Neuhoff, Jenny Landsberg, et al.
Frontiers in Immunology|September 20, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejectionAnn-Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 12, 2024
Second opinion and self-efficacy in German skin cancer patientsHenner Stege, Sara Schneider, Andrea Forschner, et al.
The British Journal of Dermatology|May 3, 2023
A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trialMichael Schultheis, Petra Staubach, Georgios Nikolakis, et al.
Pageof 33